100751-65-3,MFCD11044858
Catalog No.:AA0002QF

100751-65-3 | 2-(t-Butyldimethylsilyloxy)-6-bromonaphthalene

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$35.00   $25.00
- +
5g
98%
in stock  
$59.00   $42.00
- +
25g
98%
in stock  
$202.00   $142.00
- +
100g
98%
in stock  
$583.00 $408.00
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0002QF
Chemical Name:
2-(t-Butyldimethylsilyloxy)-6-bromonaphthalene
CAS Number:
100751-65-3
Molecular Formula:
C16H21BrOSi
Molecular Weight:
337.3268
MDL Number:
MFCD11044858
SMILES:
Brc1ccc2c(c1)ccc(c2)O[Si](C(C)(C)C)(C)C
Properties
Properties
 
Form:
Solid  
MP:
61-64 °C  
Storage:
Room Temperature;  

Computed Properties
 
Complexity:
310  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  

Downstream Synthesis Route

[1]CurrentPatentAssignee:UNIVERSITYOFPENNSYLVANIA-WO2008/124812,2008,A1Locationinpatent:Page/Pagecolumn48-49

[2]Pinto-BazurcoMendieta,MarianoA.E.;Negri,Matthias;Jagusch,Carsten;Hille,UlrikeE.;Mueller-Vieira,Ursula;Schmidt,Dirk;Hansen,Klaus;Hartmann,RolfW.[BioorganicandMedicinalChemistryLetters,2008,vol.18,#1,p.267-273]

[3]Mewshaw,RichardE.;EdsallJr.,RichardJ.;Yang,Cuijian;Manas,EricS.;Xu,ZhangB.;Henderson,RuthA.;KeithJr.,JamesC.;Harris,HeatherA.[JournalofMedicinalChemistry,2005,vol.48,#12,p.3953-3979]

[4]Locationinpatent:experimentalpartPinto-BazurcoMendieta,MarianoA.E.;Negri,Matthias;Hu,Qingzhong;Hille,UlrikeE.;Jagusch,Carsten;Jahn-Hoffmann,Kerstin;Mueller-Vieira,Ursula;Schmidt,Dirk;Lauterbach,Thomas;Hartmann,RolfW.[ArchivderPharmazie,2008,vol.341,#10,p.547-609]

[5]Locationinpatent:experimentalpartKaku,Tomohiro;Matsunaga,Nobuyuki;Ojida,Akio;Tanaka,Toshimasa;Hara,Takahito;Yamaoka,Masuo;Kusaka,Masami;Tasaka,Akihiro[BioorganicandMedicinalChemistry,2011,vol.19,#5,p.1751-1770]

[6]CurrentPatentAssignee:ARIZONABOARDOFREGENTS-WO2011/41529,2011,A2Locationinpatent:Page/Pagecolumn13

[7]He,Zhen;Pulis,AlexanderP.;Procter,DavidJ.[AngewandteChemie-InternationalEdition,2019,vol.58,#23,p.7813-7817][Angew.Chem.,2019,vol.131,#23,p.7895-7899,5]

[8]Wallimann,Peter;Mattei,Sebastiane;Seiler,Paul;Diederich,Francois[HelveticaChimicaActa,1997,vol.80,#8,p.2368-2390]

[9]Rui,Marta;Rossi,Daniela;Marra,Annamaria;Paolillo,Mayra;Schinelli,Sergio;Curti,Daniela;Tesei,Anna;Cortesi,Michela;Zamagni,Alice;Laurini,Erik;Pricl,Sabrina;Schepmann,Dirk;Wűnsch,Bernhard;Urban,Ernst;Pace,Vittorio;Collina,Simona[EuropeanJournalofMedicinalChemistry,2016,vol.124,p.649-665]

[10]Locationinpatent:experimentalpartCelen,Sofie;Cleynhens,Jan;Deroose,Christophe;deGroot,Tjibbe;Ibrahimi,Abdelilah;Gijsbers,Rik;Debyser,Zeger;Mortelmans,Luc;Verbruggen,Alfons;Bormans,Guy[BioorganicandMedicinalChemistry,2009,vol.17,#14,p.5117-5125]

[11]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2005/108338,2005,A1Locationinpatent:Page/Pagecolumn48-49

[12]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2007/28104,2007,A2Locationinpatent:Page/Pagecolumn51-52

[13]CurrentPatentAssignee:LYCIATHERAPEUTICS-WO2021/142377,2021,A2Locationinpatent:Paragraph00885-00886

[14]CurrentPatentAssignee:BIOGENIDECINC.-WO2011/17561,2011,A1Locationinpatent:Page/Pagecolumn82-83

[15]Wiensch,EricM.;Montgomery,John[AngewandteChemie-InternationalEdition,2018,vol.57,#34,p.11045-11049][Angew.Chem.,2018,vol.130,#34,p.11211-11215,5]

[16]CurrentPatentAssignee:MERCK&COINC-US5006519,1991,A

[17]CurrentPatentAssignee:GruenenthalPharmaGmbH&Co.Kommanditgesellschaft-US2003/232891,2003,A1Locationinpatent:Page/Pagecolumn39

[18]Kanao,Miki;Higuchi,Masayoshi[ChemistryLetters,2014,vol.43,#7,p.1075-1077]

[19]Rui,Marta;Marra,Annamaria;Pace,Vittorio;Juza,Markus;Rossi,Daniela;Collina,Simona[Molecules,2016,vol.21,#9]

[1]JournalofMedicinalChemistry,2005,vol.48,p.3953-3979

[2]Patent:WO2008/124812,2008,A1

[1]Patent:WO2005/108338,2005,A1.Locationinpatent:Page/Pagecolumn49-50

[2]Patent:WO2007/28104,2007,A2.Locationinpatent:Page/Pagecolumn52-53

[1]CurrentPatentAssignee:PARIONSCIENCESINC-US2009/214444,2009,A1

[2]CurrentPatentAssignee:PARIONSCIENCESINC-US2009/214444,2009,A1

[1]Patent:WO2011/41529,2011,A2.Locationinpatent:Page/Pagecolumn12-13

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
Country:
Additional Info:
SDS
Tags:100751-65-3 Molecular Formula|100751-65-3 MDL|100751-65-3 SMILES|100751-65-3 2-(t-Butyldimethylsilyloxy)-6-bromonaphthalene
Catalog No.: AA0002QF
100751-65-3,MFCD11044858
100751-65-3 | 2-(t-Butyldimethylsilyloxy)-6-bromonaphthalene
Pack Size: 1g
Purity: 98%
in stock
$35.00 $25.00
Pack Size: 5g
Purity: 98%
in stock
$59.00 $42.00
Pack Size: 25g
Purity: 98%
in stock
$202.00 $142.00
Pack Size: 100g
Purity: 98%
in stock
$583.00 $408.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0002QF
Chemical Name: 2-(t-Butyldimethylsilyloxy)-6-bromonaphthalene
CAS Number: 100751-65-3
Molecular Formula: C16H21BrOSi
Molecular Weight: 337.3268
MDL Number: MFCD11044858
SMILES: Brc1ccc2c(c1)ccc(c2)O[Si](C(C)(C)C)(C)C
Properties
Form: Solid  
MP: 61-64 °C  
Storage: Room Temperature;  
Complexity: 310  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 19  
Hydrogen Bond Acceptor Count: 1  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 3  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
Downstream Synthesis Route
15231-91-1    18162-48-6    100751-65-3 

[1]CurrentPatentAssignee:UNIVERSITYOFPENNSYLVANIA-WO2008/124812,2008,A1Locationinpatent:Page/Pagecolumn48-49

[2]Pinto-BazurcoMendieta,MarianoA.E.;Negri,Matthias;Jagusch,Carsten;Hille,UlrikeE.;Mueller-Vieira,Ursula;Schmidt,Dirk;Hansen,Klaus;Hartmann,RolfW.[BioorganicandMedicinalChemistryLetters,2008,vol.18,#1,p.267-273]

[3]Mewshaw,RichardE.;EdsallJr.,RichardJ.;Yang,Cuijian;Manas,EricS.;Xu,ZhangB.;Henderson,RuthA.;KeithJr.,JamesC.;Harris,HeatherA.[JournalofMedicinalChemistry,2005,vol.48,#12,p.3953-3979]

[4]Locationinpatent:experimentalpartPinto-BazurcoMendieta,MarianoA.E.;Negri,Matthias;Hu,Qingzhong;Hille,UlrikeE.;Jagusch,Carsten;Jahn-Hoffmann,Kerstin;Mueller-Vieira,Ursula;Schmidt,Dirk;Lauterbach,Thomas;Hartmann,RolfW.[ArchivderPharmazie,2008,vol.341,#10,p.547-609]

[5]Locationinpatent:experimentalpartKaku,Tomohiro;Matsunaga,Nobuyuki;Ojida,Akio;Tanaka,Toshimasa;Hara,Takahito;Yamaoka,Masuo;Kusaka,Masami;Tasaka,Akihiro[BioorganicandMedicinalChemistry,2011,vol.19,#5,p.1751-1770]

[6]CurrentPatentAssignee:ARIZONABOARDOFREGENTS-WO2011/41529,2011,A2Locationinpatent:Page/Pagecolumn13

[7]He,Zhen;Pulis,AlexanderP.;Procter,DavidJ.[AngewandteChemie-InternationalEdition,2019,vol.58,#23,p.7813-7817][Angew.Chem.,2019,vol.131,#23,p.7895-7899,5]

[8]Wallimann,Peter;Mattei,Sebastiane;Seiler,Paul;Diederich,Francois[HelveticaChimicaActa,1997,vol.80,#8,p.2368-2390]

[9]Rui,Marta;Rossi,Daniela;Marra,Annamaria;Paolillo,Mayra;Schinelli,Sergio;Curti,Daniela;Tesei,Anna;Cortesi,Michela;Zamagni,Alice;Laurini,Erik;Pricl,Sabrina;Schepmann,Dirk;Wűnsch,Bernhard;Urban,Ernst;Pace,Vittorio;Collina,Simona[EuropeanJournalofMedicinalChemistry,2016,vol.124,p.649-665]

[10]Locationinpatent:experimentalpartCelen,Sofie;Cleynhens,Jan;Deroose,Christophe;deGroot,Tjibbe;Ibrahimi,Abdelilah;Gijsbers,Rik;Debyser,Zeger;Mortelmans,Luc;Verbruggen,Alfons;Bormans,Guy[BioorganicandMedicinalChemistry,2009,vol.17,#14,p.5117-5125]

[11]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2005/108338,2005,A1Locationinpatent:Page/Pagecolumn48-49

[12]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2007/28104,2007,A2Locationinpatent:Page/Pagecolumn51-52

[13]CurrentPatentAssignee:LYCIATHERAPEUTICS-WO2021/142377,2021,A2Locationinpatent:Paragraph00885-00886

[14]CurrentPatentAssignee:BIOGENIDECINC.-WO2011/17561,2011,A1Locationinpatent:Page/Pagecolumn82-83

[15]Wiensch,EricM.;Montgomery,John[AngewandteChemie-InternationalEdition,2018,vol.57,#34,p.11045-11049][Angew.Chem.,2018,vol.130,#34,p.11211-11215,5]

[16]CurrentPatentAssignee:MERCK&COINC-US5006519,1991,A

[17]CurrentPatentAssignee:GruenenthalPharmaGmbH&Co.Kommanditgesellschaft-US2003/232891,2003,A1Locationinpatent:Page/Pagecolumn39

[18]Kanao,Miki;Higuchi,Masayoshi[ChemistryLetters,2014,vol.43,#7,p.1075-1077]

[19]Rui,Marta;Marra,Annamaria;Pace,Vittorio;Juza,Markus;Rossi,Daniela;Collina,Simona[Molecules,2016,vol.21,#9]

100751-65-3    179942-45-1 

[1]JournalofMedicinalChemistry,2005,vol.48,p.3953-3979

[2]Patent:WO2008/124812,2008,A1

459423-32-6    100751-65-3    869644-45-1 

[1]Patent:WO2005/108338,2005,A1.Locationinpatent:Page/Pagecolumn49-50

[2]Patent:WO2007/28104,2007,A2.Locationinpatent:Page/Pagecolumn52-53

149965-78-6    100751-65-3    1184951-86-7 

[1]CurrentPatentAssignee:PARIONSCIENCESINC-US2009/214444,2009,A1

[2]CurrentPatentAssignee:PARIONSCIENCESINC-US2009/214444,2009,A1

622-33-3    100751-65-3    1283147-63-6 

[1]Patent:WO2011/41529,2011,A2.Locationinpatent:Page/Pagecolumn12-13

Building Blocks More >
1008961-08-7
1008961-08-7
(2,5-Dioxo-1-propyl-4-imidazolidinyl)acetic acid
AA00030X | MFCD07391220
100981-05-3
100981-05-3
5-(Bis(methylthio)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione
AA0003A2 | MFCD00107207
101079-63-4
101079-63-4
2,6-Dichloropyridine-3,4-diamine
AA0003L5 | MFCD10697689
10124-62-6
10124-62-6
1,2-Dimethoxy-1,1,2,2-tetramethyldisilane
AA0003YF | MFCD09038446
1013753-99-5
1013753-99-5
4-Piperidinecarboxamide, N-[(1S)-2-[[(2-methoxyphenyl)methyl]amino]-1-methyl-2-oxoethyl]-1-(phenylsulfonyl)-
AA00048Y | MFCD30470656
10154-71-9
10154-71-9
3-(Phenylsulfonyl)propanoic acid
AA0004OH | MFCD00010141
1016-57-5
1016-57-5
5-Methyl-1-phenyl-1h-1,2,4-triazole-3-carboxylic acid
AA0004VD | MFCD11053232
1017356-25-0
1017356-25-0
tert-Butyl 3-((methylamino)methyl)piperidine-1-carboxylate
AA00059E | MFCD08061952
10185-62-3
10185-62-3
3-(5-Methyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl chloride
AA0005N2 | MFCD06797486
1019443-66-3
1019443-66-3
2-(3-Trifluoromethylphenoxy)methylpiperidine
AA0005YB | MFCD13272699
Submit
© 2017 AA BLOCKS, INC. All rights reserved.